Next Article in Journal
Vitamin D, Hypercalciuria and Kidney Stones
Previous Article in Journal
Association between Sarcopenia and Metabolic Syndrome in Middle-Aged and Older Non-Obese Adults: A Systematic Review and Meta-Analysis
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

The Western Diet–Microbiome-Host Interaction and Its Role in Metabolic Disease

Marit K. Zinöcker
1,* and
Inge A. Lindseth
Department of Nutrition, Bjørknes University College, Lovisenberggata 13, 0456 Oslo, Norway
Balderklinikken, Munchsgate 7, 0165 Oslo, Norway
Author to whom correspondence should be addressed.
Nutrients 2018, 10(3), 365;
Submission received: 7 February 2018 / Revised: 6 March 2018 / Accepted: 14 March 2018 / Published: 17 March 2018


The dietary pattern that characterizes the Western diet is strongly associated with obesity and related metabolic diseases, but biological mechanisms supporting these associations remain largely unknown. We argue that the Western diet promotes inflammation that arises from both structural and behavioral changes in the resident microbiome. The environment created in the gut by ultra-processed foods, a hallmark of the Western diet, is an evolutionarily unique selection ground for microbes that can promote diverse forms of inflammatory disease. Recognizing the importance of the microbiome in the development of diet-related disease has implications for future research, public dietary advice as well as food production practices. Research into food patterns suggests that whole foods are a common denominator of diets associated with a low level of diet-related disease. Hence, by studying how ultra-processing changes the properties of whole foods and how these foods affect the gut microbiome, more useful dietary guidelines can be made. Innovations in food production should be focusing on enabling health in the super-organism of man and microbe, and stronger regulation of potentially hazardous components of food products is warranted.

1. Ultra-Processed Foods as Drivers of Diet-Related Disease

The share of whole versus ultra-processed foods is a dietary factor that has traditionally been given minor attention in nutritional science. However, a growing body of epidemiological research supports the idea that ultra-processed foods are detrimental to human health. Classification of foods according to processing has, among others, been reviewed by Monteiro and co-workers in the NOVA classification, where foodstuffs are grouped into categories according to the extent and purpose of processing applied to them [1]. The most extensively processed foods, termed “ultra-processed”, have been defined as “industrial formulations made entirely or mostly from substances extracted from foods (e.g., oils, fats, sugar, starch, and proteins), derived from food constituents (e.g., hydrogenated fats and modified starch), or synthesized in laboratories from food substrates or other organic sources (e.g., flavor enhancers, colors and several food additives used to make the product hyper-palatable)” [2]. The utility of the NOVA classification has been subject to discussion, as this classification is not based on unequivocal, distinct physical/chemical aspects of foods [3]. However, the NOVA classification has been acknowledged in several reports from The United Nations (UN) and World Health Organisation agencies, as well as in scientific journals [4]. Also, it is safe to conclude that ultra-processed foods are one major hallmark of the Western diet. In high-income countries, ultra-processed foods are now dominating the food supply, and they are rapidly gaining ground in growing economies [5]. Transnational food and beverage corporations are increasingly targeting low income countries, strategically using pricing and availability to increase consumption of ultra-processed foods at the expense of traditional foods [6]. Individuals consuming large amounts of these types of foods are at greater risk of being obese than people who consume relatively little [7,8,9], and the availability of ultra-processed foods is positively associated with the prevalence of obesity [10,11]. Also, the dietary share of ultra-processed foods determines the nutritional quality of diets in several populations [12,13,14].
Associations with adverse health effects in humans are also present when looking at food groups. For instance, although a high intake of meat in general is associated with an increased risk for several health outcomes [15,16,17,18,19], processed meat shows a much stronger association [20,21,22,23]. Intake of whole grains is associated with a reduced risk of several non-communicable diseases, as opposed to refined grains [24,25]. A study on fish intake reported adverse effects on markers of metabolic syndrome from processed fish, whereas whole fish seems to be protective [26]. These studies indicate that by studying how processed foods and whole foods affect human physiology and metabolism differently, we can shed light on the mechanisms of the adverse effects of the Western diet. Nutrition researchers have tended to focus their attention on characteristics of the Western diet such as the energy density and the addition of fat, sugar and salt. We argue that other factors introduced during food processing can have an equally important effect by promoting inflammation-related processes through diet–microbiome–host interactions.

2. Factors that Promote Inflammation through Diet-Microbiome-Host Interactions

The microbiota composition can change rapidly upon dietary changes [27] and contribute to negative health effects, as evidenced by microbe transplant studies in rodents. Such changes can include dysbiosis and microbiota encroachment, leading to inflammation and metabolic disturbances [28,29,30]. However, a change in microbiota composition is not a prerequisite for changes in function. Dietary factors that alter the metabolic behavior of the microbes already present can also have a large impact. Gut bacteria adjust their metabolism according to both the substances produced by other microbes and the nutrient supply, which may produce effects that influence metabolic and inflammatory pathways in the human body [31]. For instance, both human and animal studies have demonstrated that pathogens, pathobionts and other members of the microbiome can respond to a change in their environment (e.g., the presence of some emulsifiers; discussed later) by increasing their expression of virulence factors [32,33,34], thereby increasing the pro-inflammatory potential of the microbiome.
Major changes in the diet and subsequent changes in microbiota can, at least to some extent, be reversed within the same generation. However, recent studies in rodents have demonstrated that the loss of microbiota diversity due to dietary changes can be transferred to later generations, with progressive loss of diversity [35]. Also, a Western diet could lead to a permanent loss of bacteria important to microbiome function [36] and possibly induce inheritable metabolic changes via the epigenome [37]. In sum, the environment created in the gut by ultra-processed foods could be an evolutionarily unique selection ground for microbes with behaviors that promote diverse forms of inflammation-related disease.

3. Acellular Nutrients—A Major Shift in Our Diets

Throughout the human evolution, nutrients had to be released from cells (with a few exceptions, such as nutrients in milk, honey and eggs) to be available for uptake by the enterocytes. However, in a Western diet, a large share of the energy is provided by acellular nutrients; a term coined by Ian Spreadbury [38]. Acellular nutrients, i.e., nutrients not contained in cells, provide microbial and human cells with more easily digestible substrates [39] that influence human absorption kinetics [40,41,42] and are likely to influence intestinal bacterial growth [38].
The share of cellular nutrients that become accessible during digestion in the gut differs from food to food, depending on the nature of the food matrix and processing that alters the properties of the outer cell [39]. Animal cells lack cell walls, and their phospholipid membranes are efficiently hydrolyzed by human digestive enzymes, liberating the cell content into the gut lumen [43]. Processing of animal foods (e.g., mincing of meat) can break the cell structures and increase the total availability of nutrients [44].
Plant cells have cell walls consisting mainly of fibre [45], making the contents of intact plant cells less available for uptake in the small intestine. During mastication, some plant cells are ruptured, and the macromolecules inside become available for hydrolyzation by human digestive enzymes in the gut. The release of nutrients from ruptured cells is dispersed along a large part of the small intestine, and, depending on the particle size and the food matrix, a fraction of the cellular nutrients will not be released at all, passing through the small intestine [41,42]. Nutrients in intact plant cells reaching the colon will become available to fibre-degrading bacteria that hydrolyze the cell walls of the intact cells.
Food processing that leads to breakage of cell walls affects the nutrient availability in the small intestine. Where whole grains of, for instance, wheat contain all of their nutrients in cells, grains that are milled to whole meal flour will contain a mixture of intact and ruptured cells, as milling of plant seeds causes a substantial portion of the cells to rupture [39]. Further refining of the seed contents will leave less of the cells intact, and, in white flour, a large share of the nutrients is acellular. Although milling was also used by pre-agricultural humans, the level of consumption of refined acellular macronutrients from milled grains during the last centuries, and especially the last five decades, is by far unprecedented in a historical context. The production of modern, ultra-processed foods also highly relies on extracted oils and starches for use as ingredients in food products. Extraction of oils and starches from seed crops renders all the nutrients acellular. The possible impact of this increased accessibility has received little attention as of today, but the unarguable large shift in the nutrient accessibility cannot be discounted in terms of possible health impacts in light of the new knowledge of the microbiome.
Increased amounts of readily accessible acellular nutrients in a Western diet might facilitate increased growth potential as well as altered composition and metabolism of the gut microbiota. It is likely that an abundance of accessible nutrients in the small intestine of animals signals a large nutrient availability and sufficient resources to expand the bacteria’s territory [32,46]. These effects could propagate further down the digestive system. Accordingly, Turnbaugh and co-workers found that a Western diet high in simple sugars caused a dramatic loss of microbial diversity in mice, coinciding with a bloom in bacteria capable of metabolizing such sugars, which are normally not present in the distal colon [30].
Territory expansion signaling could translate to increased production of virulence factors, which could damage the host directly or via increased amounts of microbes or microbial products entering the bloodstream or the intestinal wall. Indeed, increased amounts of microbes and microbial by-products, originating from the gut, are found in patients with lifestyle diseases [47,48]. Also, the duodenal microbiota differs in composition and function in normal weight as compared to obese people, providing an indication that the small intestinal microbiota is a discrete determinant of body fat mass amount, and that manipulating the duodenal microbiota, for example through diet changes, could affect fat mass [49].
Further, research has shown that, for instance, starch from grain based foods [40] and fructose from sugary drinks [50] can exceed the carbohydrate absorption capacity of the small intestine in humans and mice, respectively, providing easily accessible growth substrates for the bacteria in the distal small intestine as well as in the colon.
Cellular plant foods are likely to affect the gut microbiota in a different way. As a substantial amount of cells from whole plant foods will enter the colon in an intact state [41], this could favor the growth of bacteria that degrade fibre and produce beneficial metabolites (e.g., short chain fatty acids (SCFA)) in the competition for substrates in the human gut.
We argue that the increase in small intestinal nutrient availability from acellular, compared to cellular, foods could prove to be one decisive factor for the microbiota-mediated effects of the diet, and that the protective effects from whole plant foods on several health outcomes could be partly explained by favoring the growth of beneficial fibre-degrading bacteria in the colon.
The number of studies that have directly addressed how acellular versus cellular foods affect physiology is limited. To advance this field further there is a need for detailed investigation into how acellular and cellular meals and diets affect the microbiome in the gastrointestinal tract.

4. Food Additives

The number of food additives approved for use by the industry has been soaring over the last few decades [51]. The risk assessment conducted prior to the approval of such substances does generally not include effects on the microbiome [51], but recent studies have indicated that additives can induce microbiota-mediated adverse effects in the host (Table 1).
The increasing use of emulsifiers in food production, e.g., to improve foods’ sensory properties in low-fat formulations [52], is partly driven by innovation in specialty products for health-conscious consumers [53]. However, several studies have reported altered microbiota composition and gut inflammation in rodents fed commonly used emulsifiers [29,54,55,56].
Recent publications report that emulsifiers can act by increasing virulence factors and thereby the pro-inflammatory potential of the microbiome [33,34], and that this low grade inflammation caused by emulsifiers can promote colon carcinogenesis [57]. The accumulating data linking selected emulsifiers to gut inflammation should cause concern and call for precautionary action. However, lecithin, a substance of animal and plant tissue, which also acts as an emulsifier, has been suggested as a therapeutic agent in treatment of inflammatory bowel disease, as it could improve the re-establishment of an intact mucosal barrier in humans [58]. The contradictory effects of different types of emulsifiers underline the importance of thorough testing of every food additive on the gut microbiota before approval.
Non-caloric artificial sweeteners (NAS) have made their way from foul-tasting soft drink alternatives for diabetics, to become the choice of the masses. These sweeteners have also not been tested for effects on the gut microbiota prior to approval. Effects from rodent studies include altered composition of microbes leading to impaired glucose tolerance [28,59,60] as well as increased pro-inflammatory potential [61,62] and liver inflammation [61]. NAS-induced alterations in the microbiota composition leading to adverse metabolic outcomes should give rise to concern, especially because the demand for NAS-containing products are increasing, and persons suffering from metabolic disorders could be more likely to choose such products for health benefits. Rodent studies demonstrating the disruptive properties of artificial sweeteners on gut microbiota have been criticized for using concentrations corresponding to the acceptable daily intake (ADI) in humans, thereby exceeding a normal consumption pattern. However, the ADI is set to include a safety margin, usually by dividing the “no observed adverse effect level” by a factor of 100. An observed effect at the ADI level indicates an insufficient safety margin and calls for reassessment.

5. Other Components of the Western Diet that Influence Inflammation

A Western diet can lead to increased levels of endotoxin-producing bacteria in the intestinal tracts of both humans and mice, resulting in metabolic endotoxemia [65,66]. Several studies investigating the effect of major dietary changes on microbiota in mice have utilized so-called high fat diets, and negative changes—including metabolic endotoxemia—are often attributed to the fat content [67]. However, several other dietary factors could be contributing. An animal study demonstrated that changes in the microbiota leading to intestinal inflammation were caused by a lack of fermentable fibre, and not by the content of fat in the diet [68]. When mice were fed a diet that induced metabolic endotoxemia, adding a prebiotic improved metabolic marker [69]. Correspondingly, dietary polyphenols have shown the ability to restore gut barrier integrity [66], attenuate a number of inflammatory effects of a so-called high fat diet and to induce a healthy microbiota profile in mice when fed together with the high fat diet [70]. Thus, the Western diet’s contribution to inflammation in experimental settings could partly be explained by the low content of plant-derived nutrients, like fibre and phytochemicals.
Furthermore, diet-induced inflammation could be mediated partly by the PAMPs (pathogen associated molecular patterns) produced by microbes in processed foods [71]. PAMPs, (e.g., lipopolysaccharide (LPS) and other toll like receptor stimulants) arise from bacterial growth during periods between food preparation and heat treatment, which are likely to be prolonged in industrial processing compared to home cooking. When fresh whole foods are prepared for processing, such as mincing meat or dicing vegetables, the increase in surface area and access points favors the conditions for the growth of bacteria. Clett Erridge has demonstrated that both minimally processed (e.g., diced onions and minced meats) and more processed foods (e.g., cheeses, ice cream and chocolate) contain PAMPs capable of inducing the release of pro-inflammatory cytokines in vitro [72,73]. As these PAMPs are heat stable, they can be present after heat treatment in food products with seemingly good microbiological quality [72]. A study of human volunteers reported a reduction in white blood cell count, low density lipoprotein cholesterol, body weight and waist circumference after one week on a diet low in PAMPs, whereas the beneficial changes were reversed by a diet high in PAMPs [71]. If these effects are corroborated by more studies, then the quality assessment of industrial food products should include analyses for LPS and other toll-like receptor stimulants to avoid inflammatory responses in the host, and improved measures should be taken to limit growth of PAMP-producing bacteria during processing. As the microbiological quality of foods is generally assessed by the presence of live bacteria, the presence of inflammation-inducing bacterial molecules could be a potential food safety issue that has gone under the radar.
Reversely, probiotic or fermented foods could contain beneficial bacterial molecules left in the foods during fermentation. Studies have shown beneficial effects of fermented milk products on metabolic markers in mice [74,75,76], also independently of the presence of live probiotic bacteria, either in the product or in the gut of the recipient [77]. It has been demonstrated in vitro that metabolites from probiotic bacteria are capable of reducing the release of pro-inflammatory cytokines [78,79,80]. The exact molecules involved are yet to be identified. We suggest that bacteria-derived molecules in foods are important signals, both to the microbial community in the gut and the immune system of the host, capable of altering microbiota behavior and modulating host inflammatory responses. Hence, types of processing that generate beneficial or detrimental bacterial molecules in foods could be a relevant addition to the discussion regarding food processing.
Many foods undergo extensive heat treatment during preparation that leads to the generation of advanced glycation end products (AGEs). AGEs increase with an increased cooking time, temperature and the absence of moisture [81]. Processed foods high in fat and protein typically contain higher levels of AGEs than carbohydrate-rich foods; however, the processing of breakfast cereals and carbohydrate-rich snacks that involve extrusion and high temperatures also leaves high amounts of AGEs in the finished product [81]. The majority of dietary AGEs escape absorption in the small intestine and become substrates for microbes, capable of modifying the composition of the host microbiome both in rodents and in humans, as measured in feces [82]. Dietary restriction of AGEs can alter the microbiota composition in humans [83], but, at present, we are not aware of interventions that have investigated whether AGE-induced changes in the microbiome lead to changes in markers of disease in humans. In rats, a diet high in AGEs led to reduced levels of strains associated with positive health effects, increased levels of species associated with detrimental health effects [84,85] as well as increased colon permeability [85], but there are rodent and in vitro studies where the results appear contradictory to this [84,86,87,88]. Due to the heterogeneity and the multitude of AGEs that arise from the heat treatment of processed foods and their apparent contradictory effect, heat-treatment procedures that could have a potential detrimental effect on the gut microbiota warrant further investigation.

6. Diet-Induced Inflammation and Its Role in Metabolic Disease

To what degree findings from animal studies, which largely form the basis of this paper, are relevant for the development of metabolic disease in humans is an important consideration, and data from human studies are still scarce. However, samples from the appendix of morbidly obese patients showed adverse changes in microbiota composition compared to healthy persons [89]. The connection between gut dysbiosis, inflammation and metabolic disease is also strengthened by human studies showing gut dysbiosis in prediabetic [90], diabetic [91,92] and obese patients [93,94].
Diet-induced inflammation-related processes could interfere with our biologically fine-tuned systems for nutrient sensing and energy balance and cause food cravings and hyperphagia. In mice, withdrawal from a Western style diet caused anxiety as well as cravings of sweet, energy dense foods [95]. Also, chronic exposure to LPS in rats reduces the effect of the satiety-inducing gut peptide cholecystokinin, as well as the signaling effect of leptin on the vagus nerve [96,97]. These data are shedding some eagerly awaited light on the mechanisms of leptin resistance and can provide an explanation for the imbalance in energy intake and energy expenditure coinciding with gut inflammation as observed in mice [29]. Accordingly, a recent study reported that diet-induced dysbiosis increased gut inflammation and altered vagal gut–brain communication in rats, along with an increase in body fat accumulation [98]. Reversely, a gut microbiota fed a healthy diet produces substances that influence satiety in a positive manner. In humans, it has been shown that SCFA from the fermentation of dietary fiber activate receptors throughout the small intestine and the colon, leading to increased release of satiety-inducing gut peptides [99], and several human studies have demonstrated increased satiety and reduced hunger after the addition of fermentable carbohydrates to the diet [100]. Hence, a Western diet that induces gut-derived inflammation in the host could disturb mechanisms for maintaining energy balance and contribute to obesity and subsequent metabolic disease.

7. Why Nutrition Experts Disagree on Dietary Advice

The fact that the majority of the evidence underlying nutrition policies and dietary advice in most countries has been interpreted in a context not involving the microbiome can explain some of the persistent conflicting issues in nutritional science, for instance, regarding the role of dietary fats in health. Recent studies have demonstrated that gut bacteria have a significant influence on lipid metabolism in mice, and that hypercholesterolemia and atherosclerosis are affected by functional changes in gut microbiota [101,102]. Also, the lack of suitable diets in animal studies is a further complicating matter. A study evaluating the use of experimental diets in 35 animal studies found that only 14 per cent were using appropriate diet comparisons [103]. We argue that there is a need to re-investigate the effects of dietary fats on human health parameters, applying fatty acid compositions actually present both in ultra-processed and whole foods and interpreting them in a microbial context.
The microbial angle could also offer a plausible explanation for the conflicting outcomes of human studies of health effects from fibre and whole grains [104,105]. In whole grains, the fibre is part of the cellular structures of the food, whereas “fibre” is very broadly defined, and can, in dietary studies, refer to heterogeous food components, e.g., intact fibre in whole plant foods, bran as a byproduct of milling or fibres formed during extensive processing like extrusion [106]. Extrusion of cereal foods utilizes high heat and high pressure, and the process leads to several chemical and physical changes, including inactivation of endogenous enzymes, increased content of soluble dietary fibre and mechanical damage to the cell walls [107]. Fibre-rich foods originating from extruded grains might act very differently from fibre-rich whole foods, as demonstrated in pigs. When pigs were fed extruded grains, their microbiota changed towards a less diverse and less beneficial composition compared with the pigs that were fed untreated grains [107].

8. A Complex Problem with a Simple Solution

We argue that while we are striving to make sense of the diet–microbiome–host interaction and its role in human health, we already know enough to provide better dietary advice on how to better nourish our super-organism.
A large body of research now supports the hypothesis that the Western Diet is causing changes in gut microbiota associated with obesity and metabolic disease [67]. There also seems to be consensus that fixing the diet-induced dysbiosis is a possible approach in fighting the obesity epidemic [108]. Several researchers speak of the promising potential of gut microbiota-modifying therapies, such as probiotics, prebiotics, synbiotics or fecal microbiota transplants and the need for more research into these topics [67].
We argue that, first of all, we need to fix the food. We need to provide a better and more updated answer to the question: What should we eat? The question appears to have a rather simple answer provided by our evolutionary history: Eat mostly whole foods. This approach corresponds with findings from a wide range of nutritional studies where whole foods are consistently associated with good health.

9. Future Directions

We argue that we need to study how whole foods differ from the ultra-processed foods that are characteristic of the Western diet and how these foods differentially affect our microbiome. The characterization of our food supply is still incomplete in terms of predicting health effects.
Furthermore, as outlined in this paper, an average Western diet contains several stressors that have pathological potential as single factors. The sequence order, time frame and synchronicity of different environmental stressors, a few of which are discussed here, that have the potential to disrupt homeostatic balance in the human body are seldom emphasized. Models that take the “multiple hits” scenario into account are thus strongly needed to elucidate the total effects of a Western diet and how single factors interact with an environment containing multiple stressors.
Future research must aim at better identifying which aspects of food processing may impose negative health effects. Also, the use of possibly hazardous food additives calls for stronger regulation, and detrimental effects on the microbiome must be ruled out prior to approval. Research into nutrition has had its emphasis on the intake of micro and macronutrients, but recent studies of the food matrix have indicated that the package that the nutrients are delivered in appears to be just as important as the intake levels. Dietary advice should aim to improve the overall quality of the diet, rather than primarily focusing on single nutrients, and dietary advice should also emphasize the importance of the extent of processing. Brazil has pioneered this work, and, to our knowledge, was the first country to include advice to limit the intake of fast-foods and ultra-processed foods in their official dietary advice [109].
To improve food production practices, we propose a new, governmentally-directed labeling system, where processed foods are labeled by the level of processing, the addition of additives and other substitutions for raw material as well as by the percentage of whole foods present in the finished product. Such a system could facilitate increased taxation on ultra-processed foods. Tax income could subsidize whole and minimally processed foods, to enable these foods to stand out as better alternatives—also in low income populations. To minimize resistance from food industry lobbyists, such a system should be initiated at a transnational level. The United Nations General Assembly has proclaimed 2016–2025 the UN Decade of Action on Nutrition, aimed at fighting all forms of malnutrition and call for accelerated, coordinated, global action on nutrition [110]. In this context, our suggested labeling system could be a game-changer, providing a strong incentive for increased use of whole foods at the expense of processed food ingredients in future food production, to enable future symbiotic co-existence with our inner microbial world.


This work has not been funded. The costs for open access publishing were covered by Bjørknes University College and Balderklinikken.

Author Contributions

M.K.Z. and I.A.L. both contributed to the idea, research, writing and editing of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.


  1. Monteiro, C.A.; Levy, R.B.; Claro, R.M.; de Castro, I.R.R.; Cannon, G. A new classification of foods based on the extent and purpose of their processing. Cad. Saude Publica 2010, 26, 2039–2049. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Ministry of Health of Brazil. Dietary Guidelines for the Brazilian Population. Secretariat of Health Care Primary Health Care Department. 2015. Available online: (accessed on on 1 February 2018).
  3. Gibney, M.J.; Forde, C.G.; Mullally, D.; Gibney, E.R. Ultra-processed foods in human health: A critical appraisal. Am. J. Clin. Nutr. 2017, 106, 717–724. [Google Scholar] [CrossRef] [PubMed]
  4. Monteiro, C.A.; Cannon, G.; Moubarac, J.-C.; Levy, R.B.; Louzada, M.L.C.; Jaime, P.C. The UN Decade of Nutrition, the NOVA food classification and the trouble with ultra-processing. Public Health Nutr. 2018, 21, 5–17. [Google Scholar] [CrossRef] [PubMed]
  5. Monteiro, C.A.; Moubarac, J.-C.; Cannon, G.; Ng, S.W.; Popkin, B. Ultra-processed products are becoming dominant in the global food system. Obes. Rev. Off. J. Int. Assoc. Study Obes. 2013, 14 (Suppl. 2), 21–28. [Google Scholar] [CrossRef] [PubMed]
  6. Baker, P.; Friel, S. Food systems transformations, ultra-processed food markets and the nutrition transition in Asia. Glob. Health 2016, 12, 80. [Google Scholar] [CrossRef] [PubMed]
  7. De Mendonça, R.D.; Pimenta, A.M.; Gea, A.; de la Fuente-Arrillaga, C.; Martinez-Gonzalez, M.A.; Lopes, A.C.S.; Bes-Rastrollo, M. Ultraprocessed food consumption and risk of overweight and obesity: The University of Navarra Follow-Up (SUN) cohort study. Am. J. Clin Nutr. 2016, 104, 1433–1440. [Google Scholar] [CrossRef] [PubMed]
  8. Costa, C.S.; Del-Ponte, B.; Assunção, M.C.F.; Santos, I.S. Consumption of ultra-processed foods and body fat during childhood and adolescence: A systematic review. Public Health Nutr. 2018, 21, 148–159. [Google Scholar] [CrossRef] [PubMed]
  9. De Melo, I.S.V.; Costa, C.A.C.B.; Santos, J.V.L.D.; Santos, A.F.D.; de Florêncio, T.M.; Bueno, N.B. Consumption of minimally processed food is inversely associated with excess weight in adolescents living in an underdeveloped city. PLoS ONE 2017, 12, e0188401. [Google Scholar]
  10. Monteiro, C.A.; Moubarac, J.-C.; Levy, R.B.; Canella, D.S.; da Louzada, M.L.C.; Cannon, G. Household availability of ultra-processed foods and obesity in nineteen European countries. Public Health Nutr. 2018, 21, 18–26. [Google Scholar] [CrossRef] [PubMed]
  11. Canella, D.S.; Levy, R.B.; Martins, A.P.B.; Claro, R.M.; Moubarac, J.-C.; Baraldi, L.G.; Cannon, G.; Monteiro, C.A. Ultra-processed food products and obesity in Brazilian households (2008–2009). PLoS ONE 2014, 9, e92752. [Google Scholar] [CrossRef] [PubMed]
  12. Martínez Steele, E.; Popkin, B.M.; Swinburn, B.; Monteiro, C.A. The share of ultra-processed foods and the overall nutritional quality of diets in the US: Evidence from a nationally representative cross-sectional study. Popul. Health Metr. 2017, 15, 6. [Google Scholar] [CrossRef] [PubMed]
  13. Moubarac, J.-C.; Batal, M.; Louzada, M.L.; Martinez Steele, E.; Monteiro, C.A. Consumption of ultra-processed foods predicts diet quality in Canada. Appetite 2017, 108, 512–520. [Google Scholar] [CrossRef] [PubMed]
  14. Da Louzada, M.L.C.; Ricardo, C.Z.; Steele, E.M.; Levy, R.B.; Cannon, G.; Monteiro, C.A. The share of ultra-processed foods determines the overall nutritional quality of diets in Brazil. Public Health Nutr. 2018, 21, 94–102. [Google Scholar] [CrossRef] [PubMed]
  15. Mozaffarian, D.; Hao, T.; Rimm, E.B.; Willett, W.C.; Hu, F.B. Changes in diet and lifestyle and long-term weight gain in women and men. N. Engl. J. Med. 2011, 364, 2392–2404. [Google Scholar] [CrossRef] [PubMed]
  16. Yip, C.S.C.; Lam, W.; Fielding, R. A summary of meat intakes and health burdens. Eur. J. Clin. Nutr. 2018, 72, 18–29. [Google Scholar] [CrossRef] [PubMed]
  17. Pan, A.; Sun, Q.; Bernstein, A.M.; Manson, J.E.; Willett, W.C.; Hu, F.B. Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: Three cohorts of US men and women. JAMA Intern. Med. 2013, 173, 1328–1335. [Google Scholar] [CrossRef] [PubMed]
  18. Pan, A.; Sun, Q.; Bernstein, A.M.; Schulze, M.B.; Manson, J.E.; Stampfer, M.J.; Willett, W.C.; Hu, F.B. Red meat consumption and mortality: Results from 2 prospective cohort studies. Arch. Intern. Med. 2012, 172, 555–563. [Google Scholar] [PubMed]
  19. Chan, D.S.M.; Lau, R.; Aune, D.; Vieira, R.; Greenwood, D.C.; Kampman, E.; Norat, T. Red and processed meat and colorectal cancer incidence: Meta-analysis of prospective studies. PLoS ONE 2011, 6, e20456. [Google Scholar] [CrossRef] [PubMed]
  20. Larsson, S.C.; Orsini, N. Red meat and processed meat consumption and all-cause mortality: A meta-analysis. Am. J. Epidemiol. 2014, 179, 282–289. [Google Scholar] [CrossRef] [PubMed]
  21. Bouvard, V.; Loomis, D.; Guyton, K.Z.; Grosse, Y.; Ghissassi, F.E.; Benbrahim-Tallaa, L.; Guha, N.; Mattock, H.; Straif, K. International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015, 16, 1599–1600. [Google Scholar] [CrossRef]
  22. Micha, R.; Michas, G.; Mozaffarian, D. Unprocessed Red and Processed Meats and Risk of Coronary Artery Disease and Type 2 Diabetes–An Updated Review of the Evidence. Curr. Atheroscler. Rep. 2012, 14, 515–524. [Google Scholar] [CrossRef] [PubMed]
  23. Kouvari, M.; Notara, V.; Kalogeropoulos, N.; Panagiotakos, D.B. Diabetes mellitus associated with processed and unprocessed red meat: An overview. Int. J. Food Sci. Nutr. 2016, 67, 735–743. [Google Scholar] [CrossRef] [PubMed]
  24. Aune, D.; Norat, T.; Romundstad, P.; Vatten, L.J. Whole grain and refined grain consumption and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies. Eur. J. Epidemiol. 2013, 28, 845–858. [Google Scholar] [CrossRef] [PubMed]
  25. Aune, D.; Keum, N.; Giovannucci, E.; Fadnes, L.T.; Boffetta, P.; Greenwood, D.C.; Tonstad, S.; Vatten, L.J.; Riboli, E.; Nora, T. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: Systematic review and dose-response meta-analysis of prospective studies. BMJ 2016, 353, i2716. [Google Scholar] [CrossRef] [PubMed]
  26. Tørris, C.; Molin, M.; Småstuen, M.C. Lean Fish Consumption Is Associated with Beneficial Changes in the Metabolic Syndrome Components: A 13-Year Follow-Up Study from the Norwegian Tromsø Study. Nutrients 2017, 9, 247. [Google Scholar] [CrossRef] [PubMed]
  27. David, L.A.; Maurice, C.F.; Carmody, R.N.; Gootenberg, D.B.; Button, J.E.; Wolfe, B.E.; Ling, A.V.; Devlin, A.S.; Varma, Y.; Fischbach, M.A.; et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505, 559–563. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Suez, J.; Korem, T.; Zeevi, D.; Zilberman-Schapira, G.; Thaiss, C.A.; Maza, O.; Israeli, D.; Zmora, N.; Gilad, S.; Weinberger, A.; et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014, 514, 181–186. [Google Scholar] [CrossRef] [PubMed]
  29. Chassaing, B.; Koren, O.; Goodrich, J.K.; Poole, A.C.; Srinivasan, S.; Ley, R.E.; Gewirtz, A.T. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015, 519, 92–96. [Google Scholar] [CrossRef] [PubMed]
  30. Turnbaugh, P.J.; Bäckhed, F.; Fulton, L.; Gordon, J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell. Host Microbe 2008, 3, 213–223. [Google Scholar] [CrossRef] [PubMed]
  31. Stecher, B.; Maier, L.; Hardt, W.-D. “Blooming” in the gut: How dysbiosis might contribute to pathogen evolution. Nat. Rev. Microbiol. 2013, 11, 277–284. [Google Scholar] [CrossRef] [PubMed]
  32. Penttinen, R.; Kinnula, H.; Lipponen, A.; Bamford, J.K.H.; Sundberg, L.-R. High Nutrient Concentration Can Induce Virulence Factor Expression and Cause Higher Virulence in an Environmentally Transmitted Pathogen. Microb. Ecol. 2016, 72, 955–964. [Google Scholar] [CrossRef] [PubMed]
  33. Chassaing, B.; Van de Wiele, T.; Gewirtz, A. O-013 Dietary Emulsifiers Directly Impact the Human Gut Microbiota Increasing Its Pro-inflammatory Potential and Ability to Induce Intestinal Inflammation. Inflamm. Bowel Dis. 2017, 23 (Suppl. 1), S5. [Google Scholar]
  34. Collins, J.; Robinson, C.; Danhof, H.; Knetsch, C.W.; van Leeuwen, H.C.; Lawley, T.D.; Auchtung, J.M.; Britton, R.A. Dietary trehalose enhances virulence of epidemic Clostridium difficile. Nature 2018, 553, 291–294. [Google Scholar] [CrossRef] [PubMed]
  35. Sonnenburg, E.D.; Smits, S.A.; Tikhonov, M.; Higginbottom, S.K.; Wingreen, N.S.; Sonnenburg, J.L. Diet-induced extinctions in the gut microbiota compound over generations. Nature 2016, 529, 212–215. [Google Scholar] [CrossRef] [PubMed]
  36. Thaiss, C.A.; Itav, S.; Rothschild, D.; Meijer, M.; Levy, M.; Moresi, C.; Dohnalová, L.; Braverman, S.; Rozin, S.; Malitsky, S.; et al. Persistent microbiome alterations modulate the rate of post-dieting weight regain. Nature 2016, 24. [Google Scholar] [CrossRef] [PubMed]
  37. Krautkramer, K.A.; Kreznar, J.H.; Romano, K.A.; Vivas, E.I.; Barrett-Wilt, G.A.; Rabaglia, M.E.; Keller, M.P.; Attie, A.D.; Rey, F.E.; Denu, J.M. Diet-Microbiota Interactions Mediate Global Epigenetic Programming in Multiple Host Tissues. Mol. Cell 2016, 64, 982–992. [Google Scholar] [CrossRef] [PubMed]
  38. Spreadbury, I. Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesity. Diabetes Metab. Syndr. Obes. Targets Ther. 2012, 5, 175–189. [Google Scholar] [CrossRef] [PubMed]
  39. Grundy, M.M.-L.; Edwards, C.H.; Mackie, A.R.; Gidley, M.J.; Butterworth, P.J.; Ellis, P.R. Re-evaluation of the mechanisms of dietary fibre and implications for macronutrient bioaccessibility, digestion and postprandial metabolism. Br. J. Nutr. 2016, 116, 816–833. [Google Scholar] [CrossRef] [PubMed]
  40. Anderson, I.H.; Levine, A.S.; Levitt, M.D. Incomplete absorption of the carbohydrate in all-purpose wheat flour. N. Engl. J. Med. 1981, 304, 891–892. [Google Scholar] [CrossRef] [PubMed]
  41. Grundy, M.M.; Lapsley, K.; Ellis, P.R. A review of the impact of processing on nutrient bioaccessibility and digestion of almonds. Int. J. Food Sci. Technol. 2016, 51, 1937–1946. [Google Scholar] [CrossRef] [PubMed]
  42. Noah, L.; Guillon, F.; Bouchet, B.; Buléon, A.; Molis, C.; Gratas, M.; Champ, M. Digestion of Carbohydrate from White Beans (Phaseolus vulgaris L.) in Healthy Humans. J. Nutr. 1998, 128, 977–985. [Google Scholar] [CrossRef] [PubMed]
  43. Cohn, J.S.; Kamili, A.; Wat, E.; Chung, R.W.S.; Tandy, S. Dietary Phospholipids and Intestinal Cholesterol Absorption. Nutrients 2010, 2, 116–127. [Google Scholar] [CrossRef] [PubMed]
  44. Pennings, B.; Groen, B.B.; Dijk, J.-W.; Van de Lange, A.; Kiskini, A.; Kuklinski, M.; Senden, J.M.; van Loon, L.J. Minced beef is more rapidly digested and absorbed than beef steak, resulting in greater postprandial protein retention in older men. Am. J. Clin Nutr. 2013, 98, 121–128. [Google Scholar] [CrossRef] [PubMed]
  45. Lodish, H.; Berk, A.; Zipursky, S.L.; Matsudaira, P.; Baltimore, D.; Darnell, J. The Dynamic Plant Cell Wall. 2000. Available online: (accessed on 29 November 2017).
  46. Stecher, B. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection. Microbiol. Spectr. 2015, 3. [Google Scholar] [CrossRef]
  47. Sato, J.; Kanazawa, A.; Ikeda, F.; Yoshihara, T.; Goto, H.; Abe, H.; Komiya, K.; Kawaguchi, M.; Shimizu, T.; Ogihara, T.; et al. Gut dysbiosis and detection of “live gut bacteria” in blood of Japanese patients with type 2 diabetes. Diabetes Care 2014, 37, 2343–2350. [Google Scholar] [CrossRef] [PubMed]
  48. Mitra, S.; Drautz-Moses, D.I.; Alhede, M.; Maw, M.T.; Liu, Y.; Purbojati, R.W.; Yap, Z.H.; Kushwaha, K.K.; Gheorghe, A.G.; Bjarnsholt, T.; et al. In silico analyses of metagenomes from human atherosclerotic plaque samples. Microbiome 2015, 3, 38. [Google Scholar] [CrossRef] [PubMed]
  49. Angelakis, E.; Armougom, F.; Carrière, F.; Bachar, D.; Laugier, R.; Lagier, J.-C.; Robert, C.; Michelle, C.; Henrissat, B.; Raoult, D.; et al. A Metagenomic Investigation of the Duodenal Microbiota Reveals Links with Obesity. PLoS ONE 2015, 10, e0137784. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Jang, C.; Hui, S.; Lu, W.; Cowan, A.J.; Morscher, R.J.; Lee, G.; Liu, W.; Tesz, G.J.; Birnbaum, M.J.; Rabinowitz, J.D. The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids. Cell Metab. 2018, 27, 351–361. [Google Scholar] [CrossRef] [PubMed]
  51. Carocho, M.; Barreiro, M.F.; Morales, P.; Ferreira, I.C.F.R. Adding Molecules to Food, Pros and Cons: A Review on Synthetic and Natural Food Additives. Compr. Rev. Food Sci. Food Saf. 2014, 13, 377–399. [Google Scholar] [CrossRef]
  52. Amini Sarteshnizi, R.; Mousavi Khaneghah, A.; Karimi, N. A review on application of hydrocolloids in meat and poultry products. Int. Food Res. J. 2015, 22, 872–887. [Google Scholar]
  53. Li, J.-M.; Nie, S.-P. The functional and nutritional aspects of hydrocolloids in foods. Food Hydrocoll. 2016, 53, 46–61. [Google Scholar] [CrossRef]
  54. Swidsinski, A.; Ung, V.; Sydora, B.C.; Loening-Baucke, V.; Doerffel, Y.; Verstraelen, H.; Fedorak, R.N. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm. Bowel Dis. 2009, 15, 359–364. [Google Scholar] [CrossRef] [PubMed]
  55. Singh, R.K.; Wheildon, N.; Ishikawa, S. Food Additive P-80 Impacts Mouse Gut Microbiota Promoting Intestinal Inflammation, Obesity and Liver Dysfunction. SOJ Microbiol. Infect. Dis. 2016, 4, 1–10. [Google Scholar] [CrossRef] [PubMed]
  56. Jiang, Z.; Zhao, M.; Zhang, H.; Li, Y.; Liu, M.; Feng, F. Antimicrobial Emulsifier-Glycerol Monolaurate Induces Metabolic Syndrome, Gut Microbiota Dysbiosis and Systemic Low-Grade Inflammation in Low-Fat Diet Fed Mice. Mol. Nutr. Food Res. 2017, 13. [Google Scholar] [CrossRef] [PubMed]
  57. Viennois, E.; Merlin, D.; Gewirtz, A.T.; Chassaing, B. Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis. Cancer Res. 2017, 77, 27–40. [Google Scholar] [CrossRef] [PubMed]
  58. Stremmel, W.; Gauss, A. Lecithin as a therapeutic agent in ulcerative colitis. Dig. Dis. Basel Switz. 2013, 31, 388–390. [Google Scholar] [CrossRef] [PubMed]
  59. Palmnäs, M.S.A.; Cowan, T.E.; Bomhof, M.R.; Su, J.; Reimer, R.A.; Vogel, H.J.; Hittel, D.S. Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PLoS ONE 2014, 9, e109841. [Google Scholar] [CrossRef] [PubMed]
  60. Bian, X.; Chi, L.; Gao, B.; Tu, P.; Ru, H.; Lu, K. The artificial sweetener acesulfame potassium affects the gut microbiome and body weight gain in CD-1 mice. PLoS ONE 2017, 12, e0178426. [Google Scholar] [CrossRef] [PubMed]
  61. Bian, X.; Tu, P.; Chi, L.; Gao, B.; Ru, H.; Lu, K. Saccharin induced liver inflammation in mice by altering the gut microbiota and its metabolic functions. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2017, 107, 530–539. [Google Scholar] [CrossRef] [PubMed]
  62. Bian, X.; Chi, L.; Gao, B.; Tu, P.; Ru, H.; Lu, K. Gut Microbiome Response to Sucralose and Its Potential Role in Inducing Liver Inflammation in Mice. Front. Physiol. 2017, 8, 487. [Google Scholar] [CrossRef] [PubMed]
  63. Guo, Z.; Martucci, N.J.; Moreno-Olivas, F.; Tako, E.; Mahler, G.J. Titanium dioxide nanoparticle ingestion alters nutrient absorption in an in vitro model of the small intestine. NanoImpact 2017, 5, 70–82. [Google Scholar] [CrossRef] [PubMed]
  64. Van den Brule, S.; Ambroise, J.; Lecloux, H.; Levard, C.; Soulas, R.; De Temmerman, P.-J.; Palmai-Pallag, M.; Marbaix, E.; Lison, D. Dietary silver nanoparticles can disturb the gut microbiota in mice. Part Fibre Toxicol. 2016, 13, 38. [Google Scholar] [CrossRef] [PubMed]
  65. Pendyala, S.; Walker, J.M.; Holt, P.R. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012, 142, 1100. [Google Scholar] [CrossRef] [PubMed]
  66. Ghosh, S.S.; Bie, J.; Wang, J.; Ghosh, S. Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/- mice--role of intestinal permeability and macrophage activation. PLoS ONE 2014, 9, e108577. [Google Scholar] [CrossRef] [PubMed]
  67. Martinez, K.B.; Leone, V.; Chang, E.B. Western diets, gut dysbiosis, and metabolic diseases: Are they linked? Gut Microbes 2017, 6, 1–13. [Google Scholar] [CrossRef] [PubMed]
  68. Chassaing, B.; Miles-Brown, J.; Pellizzon, M.; Ulman, E.; Ricci, M.; Zhang, L.; Patterson, A.D.; Vijay-Kumar, M.; Gewirtz, A.T. Lack of soluble fiber drives diet-induced adiposity in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2015, 309, G528–G541. [Google Scholar] [CrossRef] [PubMed]
  69. Everard, A.; Lazarevic, V.; Derrien, M.; Girard, M.; Muccioli, G.M.; Neyrinck, A.M.; Possemiers, S.; Van Holle, A.; François, P.; de Vos, W.M.; et al. Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice. Diabetes N. Y. 2011, 60, 2775–2786. [Google Scholar] [CrossRef] [PubMed]
  70. Roopchand, D.E.; Carmody, R.N.; Kuhn, P.; Moskal, K.; Rojas-Silva, P.; Turnbaugh, P.J.; Raskin, I. Dietary Polyphenols Promote Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-Induced Metabolic Syndrome. Diabetes 2015, 64, 2847–2858. [Google Scholar] [CrossRef] [PubMed]
  71. Herieka, M.; Faraj, T.A.; Erridge, C. Reduced dietary intake of pro-inflammatory Toll-like receptor stimulants favourably modifies markers of cardiometabolic risk in healthy men. Nutr. Metab. Cardiovasc. Dis. 2016, 26, 194–200. [Google Scholar] [CrossRef] [PubMed]
  72. Erridge, C. The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4. Br. J. Nutr. 2011, 105, 15–23. [Google Scholar] [CrossRef] [PubMed]
  73. Erridge, C. Stimulants of Toll-like receptor (TLR)-2 and TLR-4 are abundant in certain minimally-processed vegetables. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2011, 49, 1464–1467. [Google Scholar] [CrossRef] [PubMed]
  74. Chen, H.-L.; Tung, Y.-T.; Tsai, C.-L.; Lai, C.-W.; Lai, Z.-L.; Tsai, H.-C.; Lin, Y.L.; Wang, C.H.; Chen, C.M. Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice. Int. J. Obes. 2014, 38, 1172–1179. [Google Scholar] [CrossRef] [PubMed]
  75. Choi, J.-W.; Kang, H.W.; Lim, W.-C.; Kim, M.-K.; Lee, I.-Y.; Cho, H.-Y. Kefir prevented excess fat accumulation in diet-induced obese mice. Biosci. Biotechnol. Biochem. 2017, 81, 958–965. [Google Scholar] [CrossRef] [PubMed]
  76. Kim, D.-H.; Kim, H.; Jeong, D.; Kang, I.-B.; Chon, J.-W.; Kim, H.-S.; Song, K.Y.; Seo, K.H. Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: Targeted and untargeted community analysis with correlation of biomarkers. J. Nutr. Biochem. 2017, 44, 35–43. [Google Scholar] [CrossRef] [PubMed]
  77. Unno, T.; Choi, J.-H.; Hur, H.-G.; Sadowsky, M.J.; Ahn, Y.-T.; Huh, C.-S.; Kim, G.B.; Cha, C.J. Changes in human gut microbiota influenced by probiotic fermented milk ingestion. J. Dairy Sci. 2015, 98, 3568–3576. [Google Scholar] [CrossRef] [PubMed]
  78. Peña, J.A.; Li, S.Y.; Wilson, P.H.; Thibodeau, S.A.; Szary, A.J.; Versalovic, J. Genotypic and Phenotypic Studies of Murine Intestinal Lactobacilli: Species Differences in Mice with and without Colitis. Appl. Environ. Microbiol. 2004, 70, 558–568. [Google Scholar] [CrossRef] [PubMed]
  79. Ménard, S.; Candalh, C.; Bambou, J.C.; Terpend, K.; Cerf-Bensussan, N.; Heyman, M. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 2004, 53, 821–828. [Google Scholar] [CrossRef] [PubMed]
  80. Bermudez-Brito, M.; Muñoz-Quezada, S.; Gomez-Llorente, C.; Romero, F.; Gil, A. Lactobacillus rhamnosus and its cell-free culture supernatant differentially modulate inflammatory biomarkers in Escherichia coli-challenged human dendritic cells. Br. J. Nutr. 2014, 111, 1727–1737. [Google Scholar] [CrossRef] [PubMed]
  81. Goldberg, T.; Cai, W.; Peppa, M.; Dardaine, V.; Baliga, B.S.; Uribarri, J.; Vlassara, H. Advanced glycoxidation end products in commonly consumed foods. J. Am. Diet. Assoc. 2004, 104, 1287–1291. [Google Scholar] [CrossRef] [PubMed]
  82. Seiquer, I.; Rubio, L.A.; Peinado, M.J.; Delgado-Andrade, C.; Navarro, M.P. Maillard reaction products modulate gut microbiota composition in adolescents. Mol. Nutr. Food Res. 2014, 58, 1552–1660. [Google Scholar] [CrossRef] [PubMed]
  83. Yacoub, R.; Nugent, M.; Cai, W.; Nadkarni, G.N.; Chaves, L.D.; Abyad, S.; Honan, A.M.; Thomas, S.A.; Zheng, W.; Valiyaparambil, S.A.; et al. Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS ONE 2017, 12, e0184789. [Google Scholar] [CrossRef] [PubMed]
  84. Delgado-Andrade, C.; de la Pastoriza Cueva, S.; Peinado, M.J.; Rufián-Henares, J.Á.; Navarro, M.P.; Rubio, L.A. Modifications in bacterial groups and short chain fatty acid production in the gut of healthy adult rats after long-term consumption of dietary Maillard reaction products. Food Res. Int. 2017, 100 Pt 1, 134–142. [Google Scholar] [CrossRef] [PubMed]
  85. Qu, W.; Yuan, X.; Zhao, J.; Zhang, Y.; Hu, J.; Wang, J.; Li, J. Dietary advanced glycation end products modify gut microbial composition and partially increase colon permeability in rats. Mol. Nutr. Food Res. 2017, 61. [Google Scholar] [CrossRef] [PubMed]
  86. ALJahdali, N.; Gadonna-Widehem, P.; Delayre-Orthez, C.; Marier, D.; Garnier, B.; Carbonero, F.; Anton, P.M. Repeated Oral Exposure to Nε-Carboxymethyllysine, a Maillard Reaction Product, Alleviates Gut Microbiota Dysbiosis in Colitic Mice. Dig. Dis Sci. 2017, 62, 3370–3384. [Google Scholar] [CrossRef] [PubMed]
  87. Anton, P.M.; Craus, A.; Niquet-Léridon, C.; Tessier, F.J. Highly heated food rich in Maillard reaction products limit an experimental colitis in mice. Food Funct. 2012, 3, 941–949. [Google Scholar] [CrossRef] [PubMed]
  88. Borrelli, R.C.; Fogliano, V. Bread crust melanoidins as potential prebiotic ingredients. Mol. Nutr. Food Res. 2005, 49, 673–678. [Google Scholar] [CrossRef] [PubMed]
  89. Moreno-Indias, I.; Sánchez-Alcoholado, L.; García-Fuentes, E.; Cardona, F.; Queipo-Ortuño, M.I.; Tinahones, F.J. Insulin resistance is associated with specific gut microbiota in appendix samples from morbidly obese patients. Am. J. Transl. Res. 2016, 8, 5672–5684. [Google Scholar] [PubMed]
  90. Allin, K.H.; Tremaroli, V.; Caesar, R.; Jensen, B.A.H.; Damgaard, M.T.F.; Bahl, M.I.; Licht, T.R.; Hansen, T.H.; Nielsen, T.; Dantoft, T.M.; et al. Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia 2018, 61, 810–820. [Google Scholar] [CrossRef] [PubMed]
  91. Qin, J.; Li, Y.; Cai, Z.; Li, S.; Zhu, J.; Zhang, F.; Liang, S.; Zhang, W.; Guan, Y.; Shen, D.; et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55–60. [Google Scholar] [CrossRef] [PubMed]
  92. Larsen, N.; Vogensen, F.K.; Berg, F.W.J.; van den Nielsen, D.S.; Andreasen, A.S.; Pedersen, B.K.; Al-Soud, W.A.; Sørensen, S.J.; Hansen, L.H.; Jakobsen, M. Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults. PLoS ONE 2010, 5, e9085. [Google Scholar] [CrossRef] [PubMed]
  93. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444, 1022–1023. [Google Scholar] [CrossRef] [PubMed]
  94. Turnbaugh, P.J.; Ley, R.E.; Mahowald, M.A.; Magrini, V.; Mardis, E.R.; Gordon, J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444, 1027–1031. [Google Scholar] [CrossRef] [PubMed]
  95. Sharma, S.; Fernandes, M.F.; Fulton, S. Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal. Int. J. Obes. 2013, 37, 1183–1191. [Google Scholar] [CrossRef] [PubMed]
  96. De La Serre, C.B.; de Lartigue, G.; Raybould, H.E. Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons. Physiol. Behav. 2015, 139, 188–194. [Google Scholar] [CrossRef] [PubMed]
  97. De Lartigue, G.; Barbier de la Serre, C.; Espero, E.; Lee, J.; Raybould, H.E. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am. J. Physiol. Endocrinol. Metab. 2011, 301, E187–E195. [Google Scholar] [CrossRef] [PubMed]
  98. Sen, T.; Cawthon, C.R.; Ihde, B.T.; Hajnal, A.; DiLorenzo, P.M.; de La Serre, C.B.; Czaja, K. Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity. Physiol. Behav. 2017, 173, 305–317. [Google Scholar] [CrossRef] [PubMed]
  99. Byrne, C.S.; Chambers, E.S.; Alhabeeb, H.; Chhina, N.; Morrison, D.J.; Preston, T.; Tedford, C.; Fitzpatrick, J.; Irani, C.; Busza, A.; et al. Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods. Am. J. Clin Nutr. 2016, 11, 5–14. [Google Scholar] [CrossRef] [PubMed]
  100. Byrne, C.S.; Chambers, E.S.; Morrison, D.J.; Frost, G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int. J. Obes. 2015, 39, 1331–1338. [Google Scholar] [CrossRef] [PubMed]
  101. Kasahara, K.; Tanoue, T.; Yamashita, T.; Yodoi, K.; Matsumoto, T.; Emoto, T.; Mizoguchi, T.; Hayashi, T.; Kitano, N.; Sasaki, N.; et al. Commensal Bacteria at the Crossroad between Cholesterol Homeostasis and Chronic Inflammation in Atherosclerosis. J. Lipid Res. 2017, 58, 519–528. [Google Scholar] [CrossRef] [PubMed]
  102. Chan, Y.K.; Brar, M.S.; Kirjavainen, P.V.; Chen, Y.; Peng, J.; Li, D.; Leung, F.C.; El-Nezam, H. High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: A pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE(-/-) mice. BMC Microbiol. 2016, 16, 264. [Google Scholar] [CrossRef]
  103. Warden, C.H.; Fisler, J.S. Comparisons of diets used in animal models of high fat feeding. Cell Metab. 2008, 7, 277. [Google Scholar] [CrossRef] [PubMed]
  104. Aune, D.; Chan, D.S.M.; Lau, R.; Vieira, R.; Greenwood, D.C.; Kampman, E. Dietary fibre, whole grains, and risk of colorectal cancer: Systematic review and dose-response meta-analysis of prospective studies. BMJ 2011, 343. [Google Scholar] [CrossRef] [PubMed]
  105. Schatzkin, A.; Mouw, T.; Park, Y.; Subar, A.F.; Kipnis, V.; Hollenbeck, A.; Leitzmann, M.F.; Thompson, F.E. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am. J. Clin. Nutr. 2007, 85, 1353–1360. [Google Scholar] [CrossRef] [PubMed]
  106. Delgado-Nieblas, C.I.; Zazueta-Morales, J.J.; Gallegos-Infante, J.A.; Aguilar-Palazuelos, E.; Camacho-Hernández, I.L.; Ordorica-Falomir, C.A. Elaboration of functional snack foods using raw materials rich in carotenoids and dietary fiber: Effects of extrusion processing. CyTA J. Food. 2015, 13, 69–79. [Google Scholar] [CrossRef]
  107. Moen, B.; Berget, I.; Rud, I.; Hole, A.S.; Kjos, N.P.; Sahlstrøm, S. Extrusion of barley and oat influence the fecal microbiota and SCFA profile of growing pigs. Food Funct. 2016, 7, 1024–1032. [Google Scholar] [CrossRef] [PubMed]
  108. Chassaing, B.; Gewirtz, A.T. Has provoking microbiota aggression driven the obesity epidemic? BioEssays News Rev. Mol. Cell Dev. Biol. 2016, 38, 122–128. [Google Scholar] [CrossRef] [PubMed]
  109. Dietary Guidelines for the Brazilian Population. Food and Agriculture Organization of the United Nations. Available online: (accessed on 3 February 2017).
  110. United Nations System Standing Committee on Nutrition. A Spotlight on the Nutrition Decade. Available online: (accessed on 1 February 2018).
Table 1. Components of a Western diet and effects on the microbiota and/or host physiology. This is not an exhaustive list. Examples are chosen based on a crude assessment of relevance to issues discussed in this paper (dosages administered are below or correspond to ADI levels, or are meant to mimic estimated intake levels in humans).
Table 1. Components of a Western diet and effects on the microbiota and/or host physiology. This is not an exhaustive list. Examples are chosen based on a crude assessment of relevance to issues discussed in this paper (dosages administered are below or correspond to ADI levels, or are meant to mimic estimated intake levels in humans).
Food AdditivesEffect on MicrobiotaEffect on Host PhysiologyOrganism/TreatmentReference
CMCBacterial overgrowthIntestinal inflammationMice (IL10−/−). 2% CMC, 3 weeks[54]
CMC, P-80Microbiota encroachment, altered species composition, increased pro-inflammatory potentialColitis, metabolic syndromeMice (IL10−/−, TLR5−/−). 1% CMC/P-80, 12 weeks
Mice (WT). 0.1–1% CMC/P-80, 12 weeks
CMC, P-80Increased pro-inflammatory potential Human colon model. 1% CMC/P-80, duration: n/a[33]
P-80Microbiota encroachment, altered species composition, increased pro-inflammatory potentialIntestinal inflammation, obesity, liver dysfunctionMice (WT). 1% P-80 per kg. bw, 4 weeks[55]
GMLGut microbiota dysbiosisMetabolic syndrome, systemic low-grade inflammationMice (WT). 150 mg·kg−1 GML, 8 weeks[56]
Titanium dioxide Decrease in absorptive microvilli, decreased nutrient uptakeHuman colon cells. 2.3 × 109 (high), 2.3 × 107 (medium), 2.3 × 105 (low) particles/mL[63]
SucraloseIncreased expression of bacterial pro-inflammatory mediatorsElevated pro-inflammatory gene expression in the liverMice (WT). 0.1 mg/mL sucralose, 6 months[62]
NASCompositional and functional alterations of microbiota associated with obesityGlucose intoleranceMice (WT). 0.1 mg/mL−1 saccharin, 5 weeks[28]
SaccharinIncreased pro-inflammatory potentialLiver inflammationMice (WT). 0.3 mg/mL saccharin, 6 months[61]
AspartameCompositional alterations of microbiotaGlucose intoleranceRats (WT). 5–7 mg/kg/d, 10 weeks[59]
Acesulfame KCompositional and functional alterations of microbiota associated with obesityWeight gain (male)Mice (CD-1). 37.5 mg/kg/d, 4 weeks[60]
Silver nanoparticlesGut microbial alterations associated with obesity and inflammatory diseases Mice (WT). 46, 460 or 4600 ppb Ag NP, 28 days[64]
Acceptable daily intake (ADI), Polysorbate 80 (P-80), Carboxymethylcellulose (CMC), Non-caloric artificial sweeteners (NAS), Glycerol Monolaureate (GML), Interleukin (IL), Toll like receptor (TLR), Wild type (WT), Not available (n/a), Body weight (bw), Cluster of differentiation 1 (CD1), Part per billion (ppb), Silver (Ag), Nanoparticles (NP).

Share and Cite

MDPI and ACS Style

Zinöcker, M.K.; Lindseth, I.A. The Western Diet–Microbiome-Host Interaction and Its Role in Metabolic Disease. Nutrients 2018, 10, 365.

AMA Style

Zinöcker MK, Lindseth IA. The Western Diet–Microbiome-Host Interaction and Its Role in Metabolic Disease. Nutrients. 2018; 10(3):365.

Chicago/Turabian Style

Zinöcker, Marit K., and Inge A. Lindseth. 2018. "The Western Diet–Microbiome-Host Interaction and Its Role in Metabolic Disease" Nutrients 10, no. 3: 365.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop